Skip to content

Clinical evidence-based study of Fuyuan Huoxue Decoction combined with extramedullary positioning osteotomy for prevention and treatment of deep vein thrombosis after total knee arthroplasty

Clinical evidence-based study of Fuyuan Huoxue Decoction combined with extramedullary positioning osteotomy for prevention and treatment of deep vein thrombosis after total knee arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084674
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

experimental Group 1:Fuyuan Huoxue Tang+conventional anticoagulation+intervention with extramedullary localization osteotomy technology
experimental Group 2:Intervention with conventional anticoagulation and extramedullary localization osteotomy technology
experimental Group 3:Intervention with conventional anticoagulation and traditional intramedullary localization osteotomy technology
experimental Group 4:Fuyuan Huoxue Tang+conventional anticoagulation+traditional intramedullary localization osteotomy intervention

Sponsors

Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) 50 years old = Enrollment age = 80 years old; (2) Those who meet KOA diagnosis and TKA surgical treatment indications; (3) No history of thrombosis related diseases within six months; (4) For first-time unilateral TKA without contraindications for implantation; (5) Color ultrasound examination of both lower limbs before surgery to exclude patients with thrombosis; (6) Able to cooperate in completing follow-up visits and have good compliance; (7) Voluntarily participate in this experiment and sign an informed consent form in writing.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the inclusion criteria; (2) Individuals with severe internal medicine underlying diseases, including heart and lung dysfunction, severe liver and kidney dysfunction, or bone marrow hematopoietic dysfunction; (3) Patients with abnormal coagulation function; (4) Individuals with allergic constitution or those who are allergic to the drugs involved in this experiment; (5) Patients with a history of gastrointestinal bleeding and a tendency to bleed; (6) Patients with severe mental illnesses; (7) Individuals who have participated in clinical trials of other investigational drugs or devices within the past three months; (8) Other researchers believe that it is not suitable for this clinical study.

Design outcomes

Primary

MeasureTime frame
Ultrasound examination of both lower limbs;

Secondary

MeasureTime frame
coagulation index;inflammatory cytokines;Lower limb circumference;visual analogue scale;hospital for special surgery knee score;

Countries

China

Contacts

Public ContactMingjiang He

Wangjing Hospital of the Chinese Academy of Traditional Chinese Medicine

bandian503@163.com+86 84739145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026